Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$1.67 -0.04 (-2.34%)
At close: Sep 10, 2026 · 4:00 PM EDT

Scinai Immunotherapeutics (SCNI) Amortizatization of Intangibles (2022 - 2026)

Scinai Immunotherapeutics' (SCNI) quarterly Amortizatization of Intangibles came in at $11000.0 in Q2 2026, up 128.21% year-over-year from $4820.2 in Q2 2025, and down 89.62% quarter-over-quarter from $106000.0 in Q1 2026.

Analysis

Scinai Immunotherapeutics (SCNI) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Scinai Immunotherapeutics has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting $11000.0 for Q2 2026.

  • In Q2 2026, Amortizatization of Intangibles rose 128.21% year-over-year to $11000.0; the TTM figure through Jun 2026 stood at $148000.0 (up 17.46% YoY), while the FY2025 annual figure was $89000.0, down 68.66% from the prior year.
  • Amortizatization of Intangibles came in at $11000.0 for Q2 2026 at Scinai Immunotherapeutics, down from $106000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $163000.0 in Q4 2022 to a low of -$39000.0 in Q2 2025.
  • Average Amortizatization of Intangibles over 5 years is $49076.9, with a median of $57000.0 recorded in 2023.
  • Year-over-year, Amortizatization of Intangibles jumped 5600.0% in 2024 and sank 134.21% in 2025.
  • Over 5 years, Amortizatization of Intangibles stood at $163000.0 in 2022, then plunged by 65.03% to $57000.0 in 2023, then slumped by 33.33% to $38000.0 in 2024, then sank by 202.63% to -$39000.0 in 2025, then surged by 128.21% to $11000.0 in 2026.
  • Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $11000.0 in Q2 2026, $106000.0 in Q1 2026, and -$39000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 600.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 1.39 Mn
10 Scinai Immunotherapeutics 1.52 Bn 1.52 Bn -1.25 Mn 11,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11,000.00
Mar 31, 2026 106,000.00
Jun 30, 2025 -39,000.00
Mar 31, 2025 70,000.00
Dec 31, 2024 38,000.00
Sep 30, 2024 57,000.00
Jun 30, 2024 114,000.00
Mar 31, 2024 75,000.00
Dec 31, 2023 57,000.00
Sep 30, 2023 2,000.00
Jun 30, 2023 2,000.00
Mar 31, 2023 -18,000.00
Dec 31, 2022 163,000.00